Morris Richard Steven
Insider CIK 1432303 · VTAE Chief Financial Officer · CARM Chief Financial Officer · PASG Chief Financial Officer · VPHM Chief Accounting Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CARM Carisma Therapeutics Inc. | A Award deriv | 2024-06-17 | 2024-06-18 | 85,000 | — | $0 | 85,000 | SEC↗ |
| CARM Carisma Therapeutics Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 170,500 | — | $0 | 170,500 | SEC↗ |
| CARM Carisma Therapeutics Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 238,000 | — | $0 | 238,000 | SEC↗ |
| CARM Carisma Therapeutics Inc. | A Award deriv | 2023-03-07 | 2023-03-09 | 331,114 | — | $0 | 331,114 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2021-05-21 | 2021-05-21 | 2,171 | $13.82 | $30.0K | 5,454 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2021-02-16 | 2021-02-18 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PASG Passage BIO, Inc. | P Buy | 2020-03-03 | 2020-03-03 | 400 | $18.00 | $7.2K | 400 | SEC↗ |
| PASG Passage BIO, Inc. | A Award deriv | 2020-02-27 | 2020-03-02 | 74,311 | — | $0 | 74,311 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 15,000 | $6.60 | $99.0K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 152,173 | $15.71 | $2.39M | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 15,000 | $12.72 | $190.8K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 27,500 | $12.22 | $336.1K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer deriv | 2016-10-25 | 2016-10-25 | 27,500 | $12.42 | $341.6K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | D To issuer | 2016-10-25 | 2016-10-25 | 828 | $21.00 | $17.4K | 0 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | A Award deriv | 2016-08-15 | 2016-08-17 | 27,500 | — | $0 | 27,500 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | A Award | 2016-04-29 | 2016-08-17 | 828 | $6.11 | $5.1K | 828 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | A Award deriv | 2016-02-15 | 2016-02-16 | 27,500 | — | $0 | 27,500 | SEC↗ |
| VTAE Vitae Pharmaceuticals, Inc | A Award deriv | 2015-02-13 | 2015-02-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2012-06-04 | 2012-06-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-03-09 | 2012-03-12 | 1,300 | — | $0 | 2,100 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-03-09 | 2012-03-12 | 1,300 | $7.05 | $9.2K | 2,544 | SEC↗ |
| VPHM VIROPHARMA INC | S Sale | 2012-03-09 | 2012-03-12 | 1,300 | $29.71 | $38.6K | 1,244 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-03-05 | 2012-03-07 | 2,000 | — | $0 | 2,000 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise deriv | 2012-03-05 | 2012-03-07 | 3,300 | — | $0 | 3,400 | SEC↗ |
| VPHM VIROPHARMA INC | S Sale | 2012-03-05 | 2012-03-07 | 5,300 | $33.01 | $175.0K | 1,244 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-03-05 | 2012-03-07 | 2,000 | $5.91 | $11.8K | 6,544 | SEC↗ |
| VPHM VIROPHARMA INC | M Exercise | 2012-03-05 | 2012-03-07 | 3,300 | $7.05 | $23.3K | 4,544 | SEC↗ |
| VPHM VIROPHARMA INC | A Award deriv | 2012-01-05 | 2012-01-06 | 6,000 | — | $0 | 6,000 | SEC↗ |